Magazine 2.4

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

Authors: lionetti R

Date: May 2019

Scope of interest: infectious/hepatological

You may also be interested in:

Report/Poster of Convention/Congress Act

Role of sedo-analgesia in execution of bone marrow biopsies

Authors: Postorino M., Rossi R., Zizzari A. G., Marchesi F., Provenzano I., Franceschini L., Pupo L., Rizzo M., .Giannì L, Gumenyuk S., De Santis G., Renzi D., Guiducci G., Fiorelli E., Coniglione F., Puliti R., Berrini A., Dauri M..

Date: 2012

Scope of interest: Haematology

Read details

Report/Poster of Convention/Congress Act

Pay attention to dementia in a middle-age man POSTER

Authors: R. Cipriani, E. Saggese ,M. Plocco P., Fabrizi V. Dell'Uomo ,M. Sebastiani ,K. Casinelli., I Uccella

Date: 2020

Scope of interest: clinical research infectious diseases

Read details

Report/Poster of Convention/Congress Act

Volumetric abnormalities of brain gray matter in genetic vulnerability to psychosis: a study of voxel based morphometry in a sample of schizophrenic patients and patients with 22q11.2 deletion

Authors: M. Frascarelli, A. Buzzanca, D. Hirsch, T. Acinni, L. Carlone, F. Ghezzi, M. Fanella, C. Lambiase, B. marina, C. Colonnese, M. Biondi, F. di Fabio

Date: 2019

Scope of interest: Neuroimaging/rare diseases/psychiatric disorders

Read details